Order Article Reprints

Schmithorst VJ, Adams PS, Badaly D, Lee VK, Wallace J, Beluk N, Votava-Smith JK, Weinberg JG, Beers SR, Detterich J, et al. Impaired Neurovascular Function Underlies Poor Neurocognitive Outcomes and Is Associated with Nitric Oxide Bioavailability in Congenital Heart Disease. Metabolites. 2022; 12(9):882. https://doi.org/10.3390/metabo12090882

Schmithorst, Vanessa J., Phillip S. Adams, Daryaneh Badaly, Vincent K. Lee, Julia Wallace, Nancy Beluk, Jodie K. Votava-Smith, Jacqueline G. Weinberg, Sue R. Beers, Jon Detterich, and et al. 2022. "Impaired Neurovascular Function Underlies Poor Neurocognitive Outcomes and Is Associated with Nitric Oxide Bioavailability in Congenital Heart Disease" Metabolites 12, no. 9: 882. https://doi.org/10.3390/metabo12090882

Schmithorst, V. J., Adams, P. S., Badaly, D., Lee, V. K., Wallace, J., Beluk, N., Votava-Smith, J. K., Weinberg, J. G., Beers, S. R., Detterich, J., Wood, J. C., Lo, C. W., & Panigrahy, A. (2022). Impaired Neurovascular Function Underlies Poor Neurocognitive Outcomes and Is Associated with Nitric Oxide Bioavailability in Congenital Heart Disease. Metabolites, 12(9), 882. https://doi.org/10.3390/metabo12090882